In my most recent Hospital Impact blog, I reinforced the simple, but significant need to focus on 3 Ps of Patient Experience, offering that at the core of this idea is the central purpose on which an ...
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a “patient” of a 340B program covered entity eligible to receive a 340B drug. In Genesis ...
The Health Resources and Services Administration’s definition of who qualifies as a patient under the 340B drug pricing program is too narrowly defined, a federal judge ruled Nov. 7. The lawsuit was ...
Guest post by Jason A. Wolf, Ph.D., president of The Beryl Institute, a global community of practice focused on patient experience improvement and founding editor of Patient Experience Journal. Follow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback